Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease

Fig. 2

KRIS proteins are inversely correlated with eGFR and eGFR slope. Baseline levels of KRIS [28] proteins in patients that received PTM were tested for association with baseline eGFR (left column), or the relative change in individual proteins of KRIS signature between the end of the trial and baseline was tested for association with eGFR slope (right column) (P < 0.1., P < 0.05*, P < 0.01**, and P < 0.001***)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us